Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Cannabinoid CB2 receptor immunolabelling in the healthy brain--still a live possibility.

Ashton JC, Zheng Y, Darlington C, Baek JH, Smith PF.

Naunyn Schmiedebergs Arch Pharmacol. 2014 Mar;387(3):301. doi: 10.1007/s00210-013-0948-y. Epub 2013 Dec 18. No abstract available.

PMID:
24346059
2.

Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina.

Cécyre B, Thomas S, Ptito M, Casanova C, Bouchard JF.

Naunyn Schmiedebergs Arch Pharmacol. 2014 Feb;387(2):175-84. doi: 10.1007/s00210-013-0930-8. Epub 2013 Nov 5.

PMID:
24185999
3.

Müller cells express the cannabinoid CB2 receptor in the vervet monkey retina.

Bouskila J, Javadi P, Casanova C, Ptito M, Bouchard JF.

J Comp Neurol. 2013 Aug 1;521(11):2399-415. doi: 10.1002/cne.23333.

PMID:
23630038
4.

Expression of CB2 cannabinoid receptor mRNA in adult rat retina.

Lu Q, Straiker A, Lu Q, Maguire G.

Vis Neurosci. 2000 Jan-Feb;17(1):91-5.

PMID:
10750830
5.

Knockout controls and the specificity of cannabinoid CB2 receptor antibodies.

Ashton JC.

Br J Pharmacol. 2011 Jul;163(6):1113; author reply 1114. doi: 10.1111/j.1476-5381.2010.01139.x. No abstract available.

6.

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.

Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR.

Brain Res. 2006 Feb 3;1071(1):10-23. Epub 2006 Feb 9.

PMID:
16472786
7.
8.

Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study.

Ashton JC, Friberg D, Darlington CL, Smith PF.

Neurosci Lett. 2006 Mar 27;396(2):113-6. Epub 2005 Dec 13.

PMID:
16356641
9.

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J.

J Neurosci. 2007 Feb 28;27(9):2396-402.

10.

CB2 cannabinoid receptor mediation of antinociception.

Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW, Porreca F, Buckley NE, Makriyannis A, Malan TP Jr.

Pain. 2006 May;122(1-2):36-42. Epub 2006 Mar 23.

PMID:
16563625
11.

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.

Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR.

Ann N Y Acad Sci. 2006 Aug;1074:514-36. Review.

PMID:
17105950
12.

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.

Akhmetshina A, Dees C, Busch N, Beer J, Sarter K, Zwerina J, Zimmer A, Distler O, Schett G, Distler JH.

Arthritis Rheum. 2009 Apr;60(4):1129-36. doi: 10.1002/art.24395.

13.

Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB₂ receptor.

Baek JH, Darlington CL, Smith PF, Ashton JC.

J Neurosci Methods. 2013 Jun 15;216(2):87-95. doi: 10.1016/j.jneumeth.2013.03.021. Epub 2013 Apr 9.

PMID:
23583232
14.

Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain.

Ashton JC, Rahman RM, Nair SM, Sutherland BA, Glass M, Appleton I.

Neurosci Lett. 2007 Jan 29;412(2):114-7. Epub 2006 Nov 22.

PMID:
17123706
15.

The use of knockout mice to test the specificity of antibodies for cannabinoid receptors.

Ashton JC.

Hippocampus. 2012 Mar;22(3):643-4. doi: 10.1002/hipo.20946. Epub 2011 May 2. No abstract available.

PMID:
21538668
16.

Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.

Hortala L, Arnaud J, Roux P, Oustric D, Boulu L, Oury-Donat F, Avenet P, Rooney T, Alagille D, Barret O, Tamagnan G, Barth F.

Bioorg Med Chem Lett. 2014 Jan 1;24(1):283-7. doi: 10.1016/j.bmcl.2013.11.023. Epub 2013 Nov 20.

PMID:
24291040
17.

Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei.

Baek JH, Zheng Y, Darlington CL, Smith PF.

Acta Otolaryngol. 2008 Sep;128(9):961-7. doi: 10.1080/00016480701796944.

PMID:
19086305
18.

Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.

Xu X, Liu Y, Huang S, Liu G, Xie C, Zhou J, Fan W, Li Q, Wang Q, Zhong D, Miao X.

Cancer Genet Cytogenet. 2006 Nov;171(1):31-8.

PMID:
17074588
19.

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.

Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E.

Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799.

20.

Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.

Han S, Thatte J, Buzard DJ, Jones RM.

J Med Chem. 2013 Nov 14;56(21):8224-56. doi: 10.1021/jm4005626. Epub 2013 Aug 8. Review.

PMID:
23865723

Supplemental Content

Support Center